Encourages the Alabama Medicaid Agency to assess GLP-1 medication costs and report findings to the Legislature.

The bill urges the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications for weight management and report its findings to the Legislature before the 2027 session. It highlights the potential savings and improved health outcomes for the state, considering the high prevalence of obesity and its economic impact. The agency is also encouraged to engage with providers and stakeholders to optimize health outcomes and cost savings.

Encourages the Alabama Medicaid Agency to assess GLP-1 medication costs and report findings to the Legislature.

The bill urges the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications for weight management and report its findings to the Legislature before the 2027 session. It highlights the potential savings and improved health outcomes for the state, considering the high prevalence of obesity and its economic impact. The agency is also encouraged to engage with providers and stakeholders to optimize health outcomes and cost savings.